An Autopsy Case of Multicentric Castleman Disease Presenting with Severe Jaundice-Reference-Cited by-同舟云学术

An Autopsy Case of Multicentric Castleman Disease Presenting with Severe Jaundice

Published:2021-11-15 Issue:22 Volume:60 Page:3615-3620
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Yamazaki Yuichi¹,Yoshida Yuka²,Shimizu Megumi¹,Kobayashi Takeshi¹,Tojima Hiroki¹,Sato Ken¹,Kakizaki Satoru¹,Handa Hiroshi³,Yokoo Hideaki²,Uraoka Toshio¹

Affiliation:

1. ¹Department of Gastroenterology and Hepatology, Gunma University Graduate School of Medicine, Japan

2. ²Department of Human Pathology, Gunma University Graduate School of Medicine, Japan

3. ⁴Department of Hematology, Gunma University Graduate School of Medicine, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/60/22/60_6835-20/_pdf

Reference18 articles.

1. 1. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer 9: 822-830, 1956.

2. 2. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 29: 670-683, 1972.

3. 3. Bowne WB, Lewis JJ, Filippa DA, et al. The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature. Cancer 85: 706-717, 1999.

4. 4. Fajgenbaum DC, Uldrick TS, Bagg A, et al. International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. Blood 129: 1646-1657, 2017.

5. 5. Liu AY, Nabel CS, Finkelman BS, et al. Idiopathic multicentric Castleman's disease: a systematic literature review. Lancet Haematol 3: e163-e175, 2016.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rare forms of idiopathic multicentric Castleman disease presenting with intrahepatic cholestatic jaundice successfully treated with the bortezomib-based regimen: two case reports;Annals of Hematology;2023-02-07